7851 - 7875 of 9038 Results
Title
Year
-
OPENTitle: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 8Start Page: e038911End Page: e038911Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2020-038911Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/8/e038911.full.pdfCitation Count: 33
- Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease2015RESTRICTEDTitle: Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 87Issue #: 8Start Page: 864End Page: 870Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2015-311827Best OA location URL: http://doi.org/10.1136/jnnp-2015-311827Citation Count: 128
-
OPENTitle: Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohortJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 89Issue #: 1Start Page: 78End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2017-316213Best OA location URL: https://escholarship.org/uc/item/3jc4p43xCitation Count: 119
-
OPENTitle: Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 88Issue #: 8Start Page: 653End Page: 662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2016-315023Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7282477Citation Count: 112
- High-accuracy Automated Diagnosis of Parkinson's Disease2019RESTRICTEDTitle: High-accuracy Automated Diagnosis of Parkinson's DiseaseJournal Name: Current Medical Imaging Formerly Current Medical Imaging ReviewsPublisher: Bentham Science Publishers Ltd.Vol: 16Issue #: 6Start Page: 688End Page: 694Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1573405615666190620113607Citation Count: 22
- Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol2016OPENTitle: Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study ProtocolJournal Name: JMIR Research ProtocolsPublisher: JMIR Publications Inc.Vol: 5Issue #: 3Start Page: e172End Page: e172Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/resprot.5990Best OA location URL: https://www.researchprotocols.org/2016/3/e172/PDFCitation Count: 73
-
OPENTitle: Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variantsJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 2Issue #: 1Start Page: e44End Page: e44Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000044Best OA location URL: https://ng.neurology.org/content/nng/2/1/e44.full.pdfCitation Count: 40
-
OPENTitle: Converging mediators from immune and trophic pathways to identify Parkinson disease dementiaJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 3Issue #: 1Start Page: e193End Page: e193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000193Best OA location URL: https://nn.neurology.org/content/nnn/3/1/e193.full.pdfCitation Count: 19
- Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion2020OPENTitle: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusionJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000711Best OA location URL: https://nn.neurology.org/content/nnn/7/3/e711.full.pdfCitation Count: 12
-
OPENTitle: Course of psychiatric symptoms and global cognition in early Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 12Start Page: 1096End Page: 1103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000801Best OA location URL: https://n.neurology.org/content/neurology/83/12/1096.full.pdfCitation Count: 121
-
OPENTitle: Association of Cortical Gyrification With Imaging and Serum Biomarkers in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 3Start Page: e311End Page: e323Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000207410Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10382266/pdf/WNL-2023-000252.pdfCitation Count: 17
-
OPENTitle: High-Throughput CSF Proteomics and Machine Learning to Identify Proteomic Signatures for Parkinson Disease Development and ProgressionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 14Start Page: e1434End Page: e1447Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000207725Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10573147/pdf/WNL-2023-000508.pdfCitation Count: 27
-
OPENTitle: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline SummaryJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 20Start Page: 942End Page: 957Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868Best OA location URL: https://n.neurology.org/content/neurology/97/20/942.full.pdfCitation Count: 189
-
OPENTitle: Screening for impulse control symptoms in patients with de novo Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 2Start Page: 176End Page: 180Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31827b915cBest OA location URL: https://n.neurology.org/content/neurology/80/2/176.full.pdfCitation Count: 189
-
OPENTitle: Leucine-rich repeat kinase 2 at a glanceJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 136Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/jcs.259724Best OA location URL: https://journals.biologists.com/jcs/article-pdf/136/17/jcs259724/3144584/jcs259724.pdfCitation Count: 19
- Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)2022RESTRICTEDTitle: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529Citation Count: 5
-
OPENTitle: Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 12Start Page: e85443End Page: e85443Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0085443Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0085443&type=printableCitation Count: 18
-
OPENTitle: Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain InjuryJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 1Start Page: e87009End Page: e87009Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0087009Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087009&type=printableCitation Count: 16
-
OPENTitle: A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 12Start Page: 113544End Page: 113544Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2023.113544Best OA location URL: https://doi.org/10.1016/j.celrep.2023.113544Citation Count: 32
- Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)2023OPENTitle: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)Journal Name: IBRO Neuroscience ReportsPublisher: Elsevier BVVol: 15Issue #:Start Page: 320End Page: 326Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001Best OA location URL: http://www.ibroneuroreports.org/article/S2667242123022716/pdfCitation Count: 0
- Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study2023OPENTitle: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control studyJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 1Start Page: fcad346End Page: fcad346Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad346Best OA location URL: https://doi.org/10.1093/braincomms/fcad346Citation Count: 6
-
OPENTitle: Gut mucosal cells transfer α-synuclein to the vagus nerveJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 8Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.172192Best OA location URL: https://doi.org/10.1172/jci.insight.172192Citation Count: 51
-
OPENTitle: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complexJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol:Issue #:Start Page: 2304End Page: 2318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231209411Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10903234/pdf/10.1177_15353702231209411.pdfCitation Count: 10
-
RESTRICTEDTitle: Altered dynamic functional network connectivity in drug-naïve Parkinson’s disease patients with excessive daytime sleepinessJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 1282962End Page: 1282962Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2023.1282962Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1282962/pdf?isPublishedV2=FalseCitation Count: 23
-
OPENTitle: Different impulse control disorder evolution patterns and white matter microstructural damage in the progression of Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 1260630End Page: 1260630Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2023.1260630Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1260630/pdf?isPublishedV2=FalseCitation Count: 0